Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer

Clinical trial NCT00006105 · COMPLETED

Trial details

NCT number: NCT00006105
Sponsor: University of Chicago
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bladder Cancer Drug/Agent Toxicity by Tissue/Organ

Start date: 2000-06-01
Primary completion: 2004-11-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.